CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis
N Ford, Z Shubber, JN Jarvis, T Chiller… - Clinical Infectious …, 2018 - academic.oup.com
Background Current guidelines recommend screening all people living with human
immunodeficiency virus (PLHIV) who have a CD4 count≤ 100 cells/µL for cryptococcal …
immunodeficiency virus (PLHIV) who have a CD4 count≤ 100 cells/µL for cryptococcal …
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
A Loyse, J Burry, J Cohn, N Ford, T Chiller… - The Lancet Infectious …, 2019 - thelancet.com
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-
related cryptococcal disease. Two strategies are recommended to reduce the high mortality …
related cryptococcal disease. Two strategies are recommended to reduce the high mortality …
Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive human immunodeficiency virus–infected adults …
Cryptococcal antigen (CrAg) screening and targeted preemptive fluconazole in antiretroviral-
naive human immunodeficiency virus–infected adults with CD4 cell counts< 100/μL seems …
naive human immunodeficiency virus–infected adults with CD4 cell counts< 100/μL seems …
[Accepted Manuscript] Impact of routine cryptococcal antigen screening and targeted pre-emptive fluconazole therapy in antiretroviral naive HIV-infected adults with …
E Temfack, JJ Bigna, HN Luma… - Clinical infectious …, 2018 - researchonline.lshtm.ac.uk
Cryptococcal antigen (CrAg) screening and targeted pre-emptive fluconazole in
antiretroviral naive HIV-infected adults with less than 100 CD4 cells/μL seems promising to …
antiretroviral naive HIV-infected adults with less than 100 CD4 cells/μL seems promising to …